Celerus raises $10M in Series C

Carpinteria, CA-based Celerus Diagnostics has raised $10 million in Series C, according to a regulatory filing. The company didn't disclose the parties involved or other details about the transaction. Celerus, which was founded in 2004, develops products that enhance the diagnostic capabilities of anatomic pathology laboratories, the company says on its website. The Celerus Wave system, which was launched in 2007, allows for immunohistochemistry test results in just 15 minutes on frozen sections or pretreated paraffin sections. Used by breast and MOHs surgeons, the system provides important tissue information during surgery, eliminating the 24 to 48 hour wait for pathology test results and the need to return for additional surgery. SEC filing | More

Suggested Articles

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.